<code id='A565B8DECB'></code><style id='A565B8DECB'></style>
    • <acronym id='A565B8DECB'></acronym>
      <center id='A565B8DECB'><center id='A565B8DECB'><tfoot id='A565B8DECB'></tfoot></center><abbr id='A565B8DECB'><dir id='A565B8DECB'><tfoot id='A565B8DECB'></tfoot><noframes id='A565B8DECB'>

    • <optgroup id='A565B8DECB'><strike id='A565B8DECB'><sup id='A565B8DECB'></sup></strike><code id='A565B8DECB'></code></optgroup>
        1. <b id='A565B8DECB'><label id='A565B8DECB'><select id='A565B8DECB'><dt id='A565B8DECB'><span id='A565B8DECB'></span></dt></select></label></b><u id='A565B8DECB'></u>
          <i id='A565B8DECB'><strike id='A565B8DECB'><tt id='A565B8DECB'><pre id='A565B8DECB'></pre></tt></strike></i>

          focus

          focus

          author:fashion    Page View:12771
          Adobe

          The Biden administration moved Wednesday to force insurance companies to give specific reasons for denying coverage, and to speed up the pre-approval process in general.

          The new rule applies to health insurance companies that offer Medicare, Medicaid, Children’s Health Insurance Program, and Obamacare plans. It concerns so-called prior authorization requests, and will require insurers to return urgent requests within 72 hours and non-urgent requests within seven days.

          advertisement

          The changes are a win for patients seeking care, but also for health care providers like hospitals and physicians. Executives from California-based Sutter Health, Massachusetts General Brigham, and others repeatedly cited the rise in insurer denials since the pandemic at last week’s J.P. Morgan Healthcare conference.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          At least 13 dead in Texas as scorching temps continue
          At least 13 dead in Texas as scorching temps continue

          1:17FirefighterEMTWilliamDorseyandfirefighterEMTRodrigoPinedatreatamigrantwomansufferingfromheatexha

          read more
          Neurocrine Biosciences, biotech based in San Diego, joins PhRMA
          Neurocrine Biosciences, biotech based in San Diego, joins PhRMA

          NeurocrineBiosciencesdecidedtojoinPhRMA.AdobeWASHINGTON—NeurocrineBiosciences,abiotechcompanybasedin

          read more
          The cancer drug shortage isn’t new — and neither are the solutions
          The cancer drug shortage isn’t new — and neither are the solutions

          PreparingachemotherapytreatmentatDukeCancerCenterinDurham,N.C.GerryBroome/APAyounggirl,maybe5or6year

          read more

          Readout Newsletter: Alnylam, Celldex, Roche, Zealand Pharma

          AdobeWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetourbiotechnewsletterinyo